Analysts' Recent Ratings Changes for Tandem Diabetes Care (TNDM)

Several analysts have recently updated their ratings and price targets for Tandem Diabetes Care (NASDAQ: TNDM): 5/22/2024 – Tandem Diabetes Care had its price target raised by analysts at Lake Street Capital from $60.00 to $75.00. They now have a “buy” rating on the stock. 5/22/2024 – Tandem Diabetes Care had its price target raised […]

Related Keywords

United States ,Leerink Partnrs ,Robertw Baird ,Stifel Nicolaus ,Piper Sandler ,Wells Fargo Company ,Citigroup Inc ,Jennison Associates ,Barclays Plc ,Gwk Investment Management ,Tandem Diabetes Care Inc ,Tandem Diabetes Care ,Lake Street Capital ,Wells Fargo ,Diabetes Care Stock Down ,Diabetes Care ,Get Free Report ,Tandem Diabetes ,Tandem Mobi ,Tandem Diabetes Care Inc Daily ,